Current migraine management – patient acceptability and future approaches
Arnaud Fumal, Jean SchoenenDepartments of Neurology and Functional Neuroanatomy, Headache Research Unit, University of Liège, BelgiumAbstract: Despite its high prevalence and individual as well as societal burden, migraine remains underdiagnosed and undertreated. In recent years, the...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2008
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/ee41f19a6f444b9c98d3fd4ee4678edf |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:ee41f19a6f444b9c98d3fd4ee4678edf |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:ee41f19a6f444b9c98d3fd4ee4678edf2021-12-02T04:34:57ZCurrent migraine management – patient acceptability and future approaches1176-63281178-2021https://doaj.org/article/ee41f19a6f444b9c98d3fd4ee4678edf2008-10-01T00:00:00Zhttp://www.dovepress.com/current-migraine-management-ndash-patient-acceptability-and-future-app-a2490https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Arnaud Fumal, Jean SchoenenDepartments of Neurology and Functional Neuroanatomy, Headache Research Unit, University of Liège, BelgiumAbstract: Despite its high prevalence and individual as well as societal burden, migraine remains underdiagnosed and undertreated. In recent years, the options for the management of migraine patients have greatly expanded. A number of drugs belonging to various pharmacological classes and deliverable by several routes are now available both for the acute and the preventive treatments of migraine. Nevertheless, disability and satisfaction remain low in many subjects because treatments are not accessible, not optimized, not effective, or simply not tolerated. There is thus still considerable room for better education, for more efficient therapies and for greater support from national health systems. In spite of useful internationally accepted guidelines, anti-migraine treatment has to be individually tailored to each patient taking into account the migraine subtype, the ensuing disability, the patient’s previous history and present expectations, and the co-morbid disorders. In this article we will summarize the phenotypic presentations of migraine and review recommendations for acute and preventive treatment, highlighting recent advances which are relevant for clinical practice in terms of both diagnosis and management.Keywords: migraine, disability, acute treatment, preventive treatment, management Jean SchoenenArnaud FumalDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2008, Iss Issue 6, Pp 1043-1057 (2008) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 |
| spellingShingle |
Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Jean Schoenen Arnaud Fumal Current migraine management – patient acceptability and future approaches |
| description |
Arnaud Fumal, Jean SchoenenDepartments of Neurology and Functional Neuroanatomy, Headache Research Unit, University of Liège, BelgiumAbstract: Despite its high prevalence and individual as well as societal burden, migraine remains underdiagnosed and undertreated. In recent years, the options for the management of migraine patients have greatly expanded. A number of drugs belonging to various pharmacological classes and deliverable by several routes are now available both for the acute and the preventive treatments of migraine. Nevertheless, disability and satisfaction remain low in many subjects because treatments are not accessible, not optimized, not effective, or simply not tolerated. There is thus still considerable room for better education, for more efficient therapies and for greater support from national health systems. In spite of useful internationally accepted guidelines, anti-migraine treatment has to be individually tailored to each patient taking into account the migraine subtype, the ensuing disability, the patient’s previous history and present expectations, and the co-morbid disorders. In this article we will summarize the phenotypic presentations of migraine and review recommendations for acute and preventive treatment, highlighting recent advances which are relevant for clinical practice in terms of both diagnosis and management.Keywords: migraine, disability, acute treatment, preventive treatment, management |
| format |
article |
| author |
Jean Schoenen Arnaud Fumal |
| author_facet |
Jean Schoenen Arnaud Fumal |
| author_sort |
Jean Schoenen |
| title |
Current migraine management – patient acceptability and future approaches |
| title_short |
Current migraine management – patient acceptability and future approaches |
| title_full |
Current migraine management – patient acceptability and future approaches |
| title_fullStr |
Current migraine management – patient acceptability and future approaches |
| title_full_unstemmed |
Current migraine management – patient acceptability and future approaches |
| title_sort |
current migraine management – patient acceptability and future approaches |
| publisher |
Dove Medical Press |
| publishDate |
2008 |
| url |
https://doaj.org/article/ee41f19a6f444b9c98d3fd4ee4678edf |
| work_keys_str_mv |
AT jeanschoenen currentmigrainemanagementampndashpatientacceptabilityandfutureapproaches AT arnaudfumal currentmigrainemanagementampndashpatientacceptabilityandfutureapproaches |
| _version_ |
1718401161558491136 |